Discovery & Development

The primary objective of this program is to address excellent hypotheses on basic biological mechanisms of tumorigenesis, progression, diagnosis, and therapy. For example, the proposed projects elucidate the molecular mechanisms of applied or new therapies, define potential target structures in tumors, identify oncogenic mutations, or serve model and method development to expand the repertoire of diagnostic assays, innovative technologies, and preclinical models. In the medium to long term, these projects can lead to a disease-specific clinical translation program.

D&D projects are advertised annually internally and funded by the FCI in the sense of a start-up aid. They should always demonstrate a long-term perspective, which will allow them to attract additional research funding in the future.

Recipients D&D funding 2020

  • Canan Arkan
  • Christian Brandts
  • Ivan Dikic
  • Fabian Finkelmeier
  • Andreas Joerger
  • Manuel Kaulich
  • Stefan Knapp
  • Sebastian Koschade
  • Daniela Krause
  • Hind Medyouf
  • Valentina Minciacchi
  • Christian Münch
  • Albrecht Piiper
  • Eugen Proschak
  • Michael Rieger
  • Michael Ronellenfitsch
  • Lisa Sevenich
  • Shabnam Shaid
  • Dieter Steinhilber
  • Winfried Wels

Recipients D&D funding 2019

  • Canan Arkan
  • Verawan Boonsanay-Michel
  • Christian Buchholz
  • Carmen Döbele
  • Volker Dötsch
  • Henner Farin
  • Emmanouil Fokas
  • Patrick Harter
  • Björn Häupl
  • Mike Heilemann
  • Manuel Kaulich
  • Stefan Knapp
  • Daniela Krause
  • Hind Medyouf
  • Christian Münch
  • Marina Pesic
  • Eva Rettinger
  • Michael Rieger
  • Rajkumar Savai
  • Constanze Schneider
  • Frank Schnütgen
  • Lisa Sevenich
  • Evelyn Ullrich
  • Thomas Vogl
  • Andreas Weigert
  • Winfried Wels